Posted in Regulatory FDA Seeks Expanded Authority To Regulate Postapproval Manufacturing Changes April 7, 2026 BioSpace Aiming to protect patients, the FDA sent lawmakers a wish list of legislative proposals intended to clarify and expand its oversight of updates to approved drug production processes. RegulatoryRead full story